Fuxiang Chen

9PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersMetabolic medicineChemotherapySeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 23, 2025
S1PR3 inhibition impairs cell cycle checkpoint via the AKT/WEE1 pathway in oral squamous cell carcinoma.

|Mar 17, 2023
LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.

Beihui Xu, Qi Li, Jianjun Zhang

|May 25, 2022
Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans.

Xu Chen, Yihua Cai, Xiaoling Hu

|Aug 29, 2021
Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.

Meng Yang, Qingqiong Luo, Xu Chen

|Jul 22, 2020
An efficient method to isolate lemon derived extracellular vesicles for gastric cancer therapy.

Meng Yang, Xiaoyan Liu, Qingqiong Luo

|Nov 23, 2019
A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8.

Francesca Nardelli, Michela Ghitti, Giacomo Quilici

Pageof 2

Frequent Collaborators

1 joint publications

Francesca Nardelli

1 joint publications

Michela Ghitti

1 joint publications

Giacomo Quilici

1 joint publications

Alessandro Gori